Laurus Labs Careers logo

Laurus Labs Careers

An India-based pharmaceutical development and manufacturing company.

lauruslabs.com

About the company

Legal name

Laurus Labs Limited

Founded

2005

Industry

Pharmaceutical development and manufacturing

Revenue (FY26)

₹6,813 crore

EBITDA (FY26)

₹1,826 crore

EBITDA margin (FY26)

26.8%

Employees

8,126

Manufacturing sites

15

CEO

Dr. Satyanarayana Chava

Laurus Labs is a research-driven pharmaceutical manufacturing organization founded in 2005. It develops and manufactures active pharmaceutical ingredients, intermediates and finished dosage forms for global pharmaceutical customers.

The company identifies anti-retroviral, oncology, cardiovascular and gastro therapeutics among the API areas where it has built capabilities. Its group also describes CDMO, biologics, pharmaceutical ingredients and finished-dosage activities.

For FY26, Laurus reported revenue from operations of ₹6,813 crore and EBITDA of ₹1,826 crore. The company reports 15 manufacturing sites, 8,126 employees and six R&D sites in its FY26 annual-report highlights.

Key People

Dr. Satyanarayana Chava

Executive Director and Chief Executive Officer

Mr. V. V. Ravi Kumar

Executive Director and Chief Financial Officer

Dr. Lakshmana Rao C V

Executive Director, Quality

Mr. Krishna Chaitanya Chava

Executive Director, CDMO Small Molecules

Photos

Laurus Labs workplace 1

Interview process at Laurus Labs

Interview experience

No numeric score verified

Interview difficulty

No numeric score verified

Interview process length

Varies by role

See all Laurus Labs interview questions & answers

Browse question banks by role, round and company, with answers and examples.

Benefits

Learning opportunities
Technology and policy learning

Latest News & Updates

May 21, 2026

Laurus Labs included in Dow Jones Best-in-Class indices

The company listed its inclusion in the Dow Jones Best-in-Class indices in its regulatory disclosures.

#Sustainability #Recognition

View post

May 13, 2026

Laurus publishes IEPF share-transfer notice

The company published a notice concerning transfer of shares to the Investor Education and Protection Fund Authority.

#Investor #Disclosure

View post

May 8, 2026

Laurus publishes second-interim-dividend TDS notice

The company published instructions for TDS documents related to its second interim FY26 dividend.

#Dividend #Investor

View post

May 2, 2026

Laurus publishes FY26 financial-results notice

The company published its newspaper notice for the quarter and year ended March 31, 2026.

#Results #Investor

View post

April 30, 2026

Laurus Labs announces full-year FY26 results

The company reported FY26 revenue of ₹6,813 crore and EBITDA of ₹1,826 crore.

#Results #Pharma

View post

Laurus Labs FAQ

Its corporate office is in Hyderabad, Telangana, India.

Last updated: